{"id":742102,"date":"2011-07-28T07:08:00","date_gmt":"2011-07-28T07:08:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/"},"modified":"2026-08-10T13:01:17","modified_gmt":"2026-08-10T17:01:17","slug":"merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/","title":{"rendered":"Merck Recognizes World Hepatitis Day With Partnerships and Grants to Support Global Hepatitis C Community"},"content":{"rendered":"<p class=\"bwalignc\">       Tune In to Hep C Benefit Concert Raises Over $250,000 for        Community-Based Groups Supporting People with Chronic Hepatitis C     <\/p>\n<p>\n      In support of World Hepatitis Day today, Merck (NYSE: MRK) (known as MSD<br \/>\n      outside the United States and Canada) reported updates on three<br \/>\n      patient-focused programs to support the hepatitis C community. These<br \/>\n      programs are part of the company&#8217;s <i>Hope Against Hepatitis C<\/i><br \/>\n      initiative, Merck&#8217;s ongoing commitment to increase awareness, prevention<br \/>\n      and diagnosis of chronic hepatitis C virus (HCV) infection. They are the<br \/>\n      latest examples of how Merck is working to deliver on its mission to<br \/>\n      help the world be well.\n    <\/p>\n<p>\n      Approximately 130 &#8211; 170 million people worldwide are chronically<br \/>\n      infected with hepatitis C, a potentially serious disease that can damage<br \/>\n      the liver over time and lead to cirrhosis, end-stage liver disease and<br \/>\n      liver cancer. In the United States, chronic hepatitis C is the most<br \/>\n      common blood-borne viral disease; approximately 3.2 million Americans<br \/>\n      have chronic HCV infection.\n    <\/p>\n<p>\n      While rates of new infection for chronic hepatitis C are dropping, the<br \/>\n      number of people with existing infection who are starting to develop<br \/>\n      serious complications, such as advanced liver disease and liver cancer,<br \/>\n      is expected to increase over the next 10 to 20 years. As a result, there<br \/>\n      is a growing need for increased awareness and education to help ensure<br \/>\n      people with chronic HCV infection are diagnosed and seek the care of a<br \/>\n      physician.\n    <\/p>\n<p>\n      <i><b>Tune In to Hep C<\/b><\/i><b> Benefit Concert Raises funds for ALF<br \/>\n      and NVHR<\/b>\n    <\/p>\n<p>\n      Rock n&#8217; Roll Hall of Fame legend Gregg Allman and GRAMMY\u00ae winner Natalie<br \/>\n      Cole performed last night at the <i>Tune In to Hep C<\/i> benefit concert<br \/>\n      in New York, raising more than $250,000 to support testing, awareness<br \/>\n      programs, and services for people with chronic HCV infection. The<br \/>\n      proceeds will be provided to the American Liver Foundation (ALF) and the<br \/>\n      National Viral Hepatitis Roundtable (NVHR). Special guests who performed<br \/>\n      at the concert included Phil Lesh of the Grateful Dead; David Crosby and<br \/>\n      Graham Nash of Crosby, Stills and Nash; and Billy Gibbons of ZZ Top, who<br \/>\n      came out to support the cause and help turn up the volume around chronic<br \/>\n      hepatitis C. The Allman Brothers Band headlined the event to support<br \/>\n      Allman in his efforts to raise awareness of chronic hepatitis C.\n    <\/p>\n<p>\n      The concert was part of <i>Tune In to Hep C<\/i>, an awareness campaign<br \/>\n      recently launched by Merck and ALF to drive awareness of this silent and<br \/>\n      progressive disease, and encourage people to talk to their doctors or<br \/>\n      healthcare providers about their options. To help drive this message,<br \/>\n      attendees at the concert previewed a new public service announcement<br \/>\n      (PSA) featuring Allman, which is set to hit the airwaves in the coming<br \/>\n      weeks. To view the PSA and learn more about the awareness campaign,<br \/>\n      please visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.TuneInToHepC.com&amp;esheet=50280011&amp;lan=en-US&amp;anchor=www.TuneInToHepC.com&amp;index=1&amp;md5=693714af35ac5ad874a1422ae55f8efd\"><span class=\"bwuline\">www.TuneInToHepC.com<\/span><\/a>.\n    <\/p>\n<p>\n      &#8220;The outpouring of community support around the campaign and the benefit<br \/>\n      concert has been remarkable, and we are grateful for the generous<br \/>\n      contribution, which will go towards helping people at risk and those<br \/>\n      infected with the chronic hepatitis C virus,&#8221; said Newton Guerin, acting<br \/>\n      CEO and chief operating officer, ALF. &#8220;However, the night was about more<br \/>\n      than the money being raised. It was about changing the negative<br \/>\n      perception of chronic hepatitis C and reminding all of us that as<br \/>\n      individuals and communities, we must take action to fight this serious<br \/>\n      public health issue.&#8221;\n    <\/p>\n<p>\n      &#8220;I was diagnosed with chronic hepatitis C more than 10 years ago, when<br \/>\n      it was relatively unknown and rarely discussed,&#8221; said Martha Saly,<br \/>\n      director of NVHR and former hepatitis C sufferer. &#8220;That changed last<br \/>\n      night when all those legendary voices came together to encourage people<br \/>\n      with hepatitis C to not let stigma or fear stand in the way of talking<br \/>\n      to their doctor.&#8221;\n    <\/p>\n<p>\n      <i><b>Step Up to The Plate Against Hepatitis C<\/b><\/i><b> Testing<br \/>\n      Initiative Takes Place at Ballparks<\/b>\n    <\/p>\n<p>\n      To encourage more people to get tested for hepatitis C, Merck, in<br \/>\n      partnership with ALF, Coalition on Positive Health Empowerment and<br \/>\n      OraSure Technologies (Nasdaq: OSUR), has launched <i>Step Up to The<br \/>\n      Plate Against Hepatitis C<\/i>. Working with participating baseball teams<br \/>\n      in Chicago, Houston and St. Louis, this initiative will offer free<br \/>\n      hepatitis C testings and educational information at baseball stadiums to<br \/>\n      encourage people to get educated on the facts and tested for hepatitis C.\n    <\/p>\n<p>\n      <b>Testing events already scheduled include:<\/b>\n    <\/p>\n<p>\n      &#8212; Chicago Cubs: August 6th, August 23rd\n    <\/p>\n<p>\n      &#8212; Chicago White Sox: August 21st, September 8th, September 13th\n    <\/p>\n<p>\n      &#8212; Houston Astros: August 20th, September 13th, September 23rd\n    <\/p>\n<p>\n      &#8212; St. Louis Cardinals: August 22nd, September 5th, September 24th\n    <\/p>\n<p>\n      To learn more about Step Up to The Plate Against Hepatitis C and other<br \/>\n      testing dates, please visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.AllAboutHepC.com%2Fbaseball&amp;esheet=50280011&amp;lan=en-US&amp;anchor=www.AllAboutHepC.com%2Fbaseball&amp;index=2&amp;md5=756476fc73419f7df8bc338632827c31\"><span class=\"bwuline\">www.AllAboutHepC.com\/baseball<\/span><\/a>.\n    <\/p>\n<p>\n      <b>Support for Global Hepatitis Initiatives<\/b>\n    <\/p>\n<p>\n      To further support World Hepatitis Day, Merck has provided a grant to<br \/>\n      the World Hepatitis Alliance (WHA), a leading global organization<br \/>\n      dedicated to preventing the spread of viral hepatitis and improving the<br \/>\n      lives of people living with the disease through better awareness,<br \/>\n      diagnosis and access to treatment and care. The organization is<br \/>\n      embarking on a variety of public education, awareness and policy<br \/>\n      initiatives to combat stigma and discrimination, while working toward<br \/>\n      developing a global viral hepatitis strategy with the World Health<br \/>\n      Organization.\n    <\/p>\n<p>\n      &#8220;Merck has been working in the hepatitis C field for 30 years, and we<br \/>\n      take our commitment to the community very seriously as a key part of our<br \/>\n      efforts to help the world be well,&#8221; said Patrick Bergstedt, senior vice<br \/>\n      president and general manager, Infectious Diseases, Global Human Health,<br \/>\n      Merck. &#8220;It is our hope that these programs, conducted in partnership<br \/>\n      with the global public health community, will have a lasting and<br \/>\n      meaningful impact on the prevention, diagnosis and management of chronic<br \/>\n      hepatitis C.&#8221;\n    <\/p>\n<p>\n      <b>About Merck<\/b>\n    <\/p>\n<p>\n      Today&#8217;s Merck is a global healthcare leader working to help the world be<br \/>\n      well. Merck is known as MSD outside the United States and Canada.<br \/>\n      Through our prescription medicines, vaccines, biologic therapies, and<br \/>\n      consumer care and animal health products, we work with customers and<br \/>\n      operate in more than 140 countries to deliver innovative health<br \/>\n      solutions. We also demonstrate our commitment to increasing access to<br \/>\n      healthcare through far-reaching policies, programs and partnerships. For<br \/>\n      more information, visit <a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.merck.com&amp;esheet=50280011&amp;lan=en-US&amp;anchor=www.merck.com&amp;index=3&amp;md5=79c1373c73bb71bf65a9d30d78c59b0e\"><span class=\"bwuline\">www.merck.com<\/span><\/a>.\n    <\/p>\n<p>\n      <b>Forward-Looking Statement<\/b>\n    <\/p>\n<p>\n      This news release includes &#8220;forward-looking statements&#8221; within the<br \/>\n      meaning of the safe harbor provisions of the United States Private<br \/>\n      Securities Litigation Reform Act of 1995. Such statements may include,<br \/>\n      but are not limited to, statements about the benefits of the merger<br \/>\n      between Merck and Schering-Plough, including future financial and<br \/>\n      operating results, the combined company&#8217;s plans, objectives,<br \/>\n      expectations and intentions and other statements that are not historical<br \/>\n      facts. Such statements are based upon the current beliefs and<br \/>\n      expectations of Merck&#8217;s management and are subject to significant risks<br \/>\n      and uncertainties. Actual results may differ from those set forth in the<br \/>\n      forward-looking statements.\n    <\/p>\n<p>\n      The following factors, among others, could cause actual results to<br \/>\n      differ from those set forth in the forward-looking statements: the<br \/>\n      possibility that the expected synergies from the merger of Merck and<br \/>\n      Schering-Plough will not be realized, or will not be realized within the<br \/>\n      expected time period; the impact of pharmaceutical industry regulation<br \/>\n      and health care legislation; the risk that the businesses will not be<br \/>\n      integrated successfully; disruption from the merger making it more<br \/>\n      difficult to maintain business and operational relationships; Merck&#8217;s<br \/>\n      ability to accurately predict future market conditions; dependence on<br \/>\n      the effectiveness of Merck&#8217;s patents and other protections for<br \/>\n      innovative products; the risk of new and changing regulation and health<br \/>\n      policies in the United States and internationally and the exposure to<br \/>\n      litigation and\/or regulatory actions.\n    <\/p>\n<p>\n      Merck undertakes no obligation to publicly update any forward-looking<br \/>\n      statement, whether as a result of new information, future events or<br \/>\n      otherwise. Additional factors that could cause results to differ<br \/>\n      materially from those described in the forward-looking statements can be<br \/>\n      found in Merck&#8217;s 2010 Annual Report on Form 10-K and the company&#8217;s other<br \/>\n      filings with the Securities and Exchange Commission (SEC) available at<br \/>\n      the SEC&#8217;s Internet site (<a href=\"http:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=50280011&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=4&amp;md5=d415e4b828e304dbdab3371e01427228\"><span class=\"bwuline\">www.sec.gov<\/span><\/a>).\n    <\/p>\n<p>\n      <b>Editor&#8217;s Note: <\/b>For more information on <i>Tune In to Hep C<\/i><br \/>\n      and <i>Step Up to the Plate Against Hepatitis C<\/i>, please contact<br \/>\n      Diann Rohde of the American Liver Foundation at (646) 737-9404.\n    <\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20120516005681r1&amp;sid=sfsite1&amp;distro=nx\"><span class=\"bwct31415\"><\/span><\/p>\n<p>       American Liver Foundation<br \/>Diann Rohde, 646-737-9404     <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tune In to Hep C Benefit Concert Raises Over $250,000 for Community-Based Groups Supporting People with Chronic Hepatitis C In support of World Hepatitis Day today, Merck (NYSE: MRK) (known as MSD outside the United States and Canada) reported updates on three patient-focused programs to support the hepatitis C community. These programs are part of the company&#8217;s Hope Against Hepatitis C initiative, Merck&#8217;s ongoing commitment to increase awareness, prevention and diagnosis of chronic hepatitis C virus (HCV) infection. They are the latest examples of how Merck is working to deliver on its mission to help the world be well. Approximately 130 &#8211; 170 million people worldwide are chronically infected with hepatitis C, a potentially serious disease that can damage the liver over time and lead to cirrhosis, end-stage liver disease and liver cancer. In the United States, chronic hepatitis C is the most common blood-borne viral disease; approximately 3.2 million Americans have chronic HCV<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[53,289],"class_list":["post-742102","news_item","type-news_item","status-publish","hentry","tag-corporate-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck Recognizes World Hepatitis Day With Partnerships and Grants to Support Global Hepatitis C Community - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Recognizes World Hepatitis Day With Partnerships and Grants to Support Global Hepatitis C Community - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Tune In to Hep C Benefit Concert Raises Over $250,000 for Community-Based Groups Supporting People with Chronic Hepatitis C In support of World Hepatitis Day today, Merck (NYSE: MRK) (known as MSD outside the United States and Canada) reported updates on three patient-focused programs to support the hepatitis C community. These programs are part of the company&#039;s Hope Against Hepatitis C initiative, Merck&#039;s ongoing commitment to increase awareness, prevention and diagnosis of chronic hepatitis C virus (HCV) infection. They are the latest examples of how Merck is working to deliver on its mission to help the world be well. Approximately 130 - 170 million people worldwide are chronically infected with hepatitis C, a potentially serious disease that can damage the liver over time and lead to cirrhosis, end-stage liver disease and liver cancer. In the United States, chronic hepatitis C is the most common blood-borne viral disease; approximately 3.2 million Americans have chronic HCV\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-10T17:01:17+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20120516005681r1&amp;sid=sfsite1&amp;distro=nx\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\\\/\",\"name\":\"Merck Recognizes World Hepatitis Day With Partnerships and Grants to Support Global Hepatitis C Community - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20120516005681r1&amp;sid=sfsite1&amp;distro=nx\",\"datePublished\":\"2011-07-28T07:08:00+00:00\",\"dateModified\":\"2026-08-10T17:01:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\\\/#primaryimage\",\"url\":\"http:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20120516005681r1&amp;sid=sfsite1&amp;distro=nx\",\"contentUrl\":\"http:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20120516005681r1&amp;sid=sfsite1&amp;distro=nx\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Recognizes World Hepatitis Day With Partnerships and Grants to Support Global Hepatitis C Community\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck Recognizes World Hepatitis Day With Partnerships and Grants to Support Global Hepatitis C Community - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/","og_locale":"en_US","og_type":"article","og_title":"Merck Recognizes World Hepatitis Day With Partnerships and Grants to Support Global Hepatitis C Community - Merck.com","og_description":"Tune In to Hep C Benefit Concert Raises Over $250,000 for Community-Based Groups Supporting People with Chronic Hepatitis C In support of World Hepatitis Day today, Merck (NYSE: MRK) (known as MSD outside the United States and Canada) reported updates on three patient-focused programs to support the hepatitis C community. These programs are part of the company's Hope Against Hepatitis C initiative, Merck's ongoing commitment to increase awareness, prevention and diagnosis of chronic hepatitis C virus (HCV) infection. They are the latest examples of how Merck is working to deliver on its mission to help the world be well. Approximately 130 - 170 million people worldwide are chronically infected with hepatitis C, a potentially serious disease that can damage the liver over time and lead to cirrhosis, end-stage liver disease and liver cancer. In the United States, chronic hepatitis C is the most common blood-borne viral disease; approximately 3.2 million Americans have chronic HCV","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/","og_site_name":"Merck.com","article_modified_time":"2026-08-10T17:01:17+00:00","og_image":[{"url":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20120516005681r1&amp;sid=sfsite1&amp;distro=nx","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/","name":"Merck Recognizes World Hepatitis Day With Partnerships and Grants to Support Global Hepatitis C Community - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/#primaryimage"},"image":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/#primaryimage"},"thumbnailUrl":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20120516005681r1&amp;sid=sfsite1&amp;distro=nx","datePublished":"2011-07-28T07:08:00+00:00","dateModified":"2026-08-10T17:01:17+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/#primaryimage","url":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20120516005681r1&amp;sid=sfsite1&amp;distro=nx","contentUrl":"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20120516005681r1&amp;sid=sfsite1&amp;distro=nx"},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck Recognizes World Hepatitis Day With Partnerships and Grants to Support Global Hepatitis C Community"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"f2c2c0e9-cb4f-4802-996b-299980adf9a9","news_item_aria_label":"","media_files":null,"document_path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_news\/Merck-Recognizes-World-Hepatitis-Day-With-Partnerships-and-Grants-to-Support-Global-Hepatitis-C-Community-2011.pdf","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/742102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":1,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/742102\/revisions"}],"predecessor-version":[{"id":3679238,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/742102\/revisions\/3679238"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=742102"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=742102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}